Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 2 Randomised Placebo-controlled Platform Trial of Snake Venom Metalloproteinase Inhibitors for Snakebite Envenoming in Brazil and Ghana

NCT07500233 is registered in ClinicalTrials.gov with Liverpool School of Tropical Medicine as lead sponsor.

NCT NCT07500233
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07500233 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 2 Randomised Placebo-controlled Platform Trial of Snake Venom Metalloproteinase Inhibitors for Snakebite Envenoming in Brazil and Ghana
Lead sponsor
Liverpool School of Tropical Medicine
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 31, 2027
Completion date
December 31, 2028
Enrollment
504 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

snakebite